JP2012518669A5 - - Google Patents

Download PDF

Info

Publication number
JP2012518669A5
JP2012518669A5 JP2011551471A JP2011551471A JP2012518669A5 JP 2012518669 A5 JP2012518669 A5 JP 2012518669A5 JP 2011551471 A JP2011551471 A JP 2011551471A JP 2011551471 A JP2011551471 A JP 2011551471A JP 2012518669 A5 JP2012518669 A5 JP 2012518669A5
Authority
JP
Japan
Prior art keywords
use according
amino acids
surface active
natural
active protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011551471A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012518669A (ja
JP5832302B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2010/052125 external-priority patent/WO2010097344A1/en
Publication of JP2012518669A publication Critical patent/JP2012518669A/ja
Publication of JP2012518669A5 publication Critical patent/JP2012518669A5/ja
Application granted granted Critical
Publication of JP5832302B2 publication Critical patent/JP5832302B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2011551471A 2009-02-26 2010-02-19 ケラチンへの局所薬剤デリバリーにおける表面活性タンパク質の組成物、使用及び使用方法 Expired - Fee Related JP5832302B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP09153770 2009-02-26
EP09153770.4 2009-02-26
PCT/EP2010/052125 WO2010097344A1 (en) 2009-02-26 2010-02-19 Compositions, use and method for the use of surface active proteins in topical drug delivery across keratin

Publications (3)

Publication Number Publication Date
JP2012518669A JP2012518669A (ja) 2012-08-16
JP2012518669A5 true JP2012518669A5 (https=) 2014-07-31
JP5832302B2 JP5832302B2 (ja) 2015-12-16

Family

ID=40834317

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011551471A Expired - Fee Related JP5832302B2 (ja) 2009-02-26 2010-02-19 ケラチンへの局所薬剤デリバリーにおける表面活性タンパク質の組成物、使用及び使用方法

Country Status (8)

Country Link
US (1) US8758730B2 (https=)
EP (1) EP2400988B1 (https=)
JP (1) JP5832302B2 (https=)
KR (1) KR20110130440A (https=)
CN (1) CN102333546B (https=)
CA (1) CA2784516C (https=)
WO (1) WO2010097344A1 (https=)
ZA (1) ZA201203028B (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013113451A2 (en) * 2012-01-31 2013-08-08 Unilever Plc Personal care composition
CA2882279C (en) 2012-08-16 2017-07-25 Dusa Pharmaceuticals, Inc. Method of treating onychomycosis
CN103980353A (zh) * 2014-05-21 2014-08-13 乔明强 一种疏水蛋白及其组成的药物制剂
BR112018008214B1 (pt) * 2015-10-26 2021-12-14 Basf Se Métodos para reparar ou inibir a erosão dentária e para fabricar um produto de cuidado oral, dentifrício, composição, e, proteína semelhante à hidrofobina
CN112198315B (zh) * 2020-09-11 2023-10-27 杭州奥泰生物技术股份有限公司 一种采集及检测指甲或趾甲样本中滥用药物的方法
CN112791048B (zh) * 2020-12-31 2023-01-17 海南海神同洲制药有限公司 一种硝酸舍他康唑栓及其制备方法
CN115701464B (zh) * 2021-08-02 2024-06-11 江苏金太阳纺织科技股份有限公司 超疏水整理剂及其制备方法与应用

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3807915A1 (de) * 1988-03-10 1989-09-21 Wella Ag Mittel zur festigung der frisur und pflege des haares
FR2673537B1 (fr) 1991-03-08 1993-06-11 Oreal Utilisation d'agents de penetration hydrophiles dans les compositions dermatologiques pour le traitement des onychomycoses, et compositions correspondantes.
AU5914196A (en) 1995-06-12 1997-01-09 Proefstation Voor De Champignoncultuur Hydrophobins from edible fungi, genes, nucleotide sequences and dna-fragments encoding for said hydrophobins, and expression thereof
CA2231769A1 (en) * 1995-09-14 1997-03-20 James L. Sorenson Composition and method for treating diseased nails
JP4227677B2 (ja) 1996-12-10 2009-02-18 杏林製薬株式会社 被膜形成性抗真菌剤組成物
US6517863B1 (en) * 1999-01-20 2003-02-11 Usbiomaterials Corporation Compositions and methods for treating nails and adjacent tissues
GB0019283D0 (en) 2000-08-04 2000-09-27 Novartis Ag Organic compounds
FR2833490B1 (fr) 2001-12-14 2004-12-10 Oreal Utilisition cosmetique d'au moins une hydrophobine pour le traitement des matieres keratiniques et compositions mises en oeuvre
US6899890B2 (en) * 2002-03-20 2005-05-31 Kv Pharmaceutical Company Bioadhesive drug delivery system
ATE315579T1 (de) 2002-06-21 2006-02-15 Applied Nanosystems Bv Verfahren zur bindung einer verbindung an eine oberfläche
JP5250264B2 (ja) 2005-02-07 2013-07-31 ビーエーエスエフ ソシエタス・ヨーロピア 新規ハイドロフォビン融合タンパク質、その製造および使用
JP4964227B2 (ja) 2005-03-30 2012-06-27 ビーエーエスエフ ソシエタス・ヨーロピア 硬化無機物建材、自然石、人造石、及びセラミックの表面処理用のハイドロフォビンの使用方法
WO2006103638A2 (en) 2005-03-31 2006-10-05 Ranbaxy Laboratories Limited Topical pharmaceutical compositions of terbinafine and processes for their preparation
EP1868698A1 (de) 2005-04-01 2007-12-26 Basf Aktiengesellschaft Verwendung von proteinen als demulgatoren
DE102005029704A1 (de) * 2005-06-24 2007-01-11 Basf Ag Verwendung von Hydrophobin-Polypeptiden sowie Konjugaten aus Hydrophobin-Polypeptiden mit Wirk-oder Effektstoffen und ihre Herstellung sowie deren Einsatz in der Kosmetik
DE102005033002A1 (de) 2005-07-14 2007-01-18 Basf Ag Wässrige Monomeremulsionen enthaltend Hydrophobin
FR2892023B1 (fr) * 2005-10-14 2009-09-25 Galderma Sa Composition pharmaceutique a base d'amorolfine et d'agent filmogene hydrosoluble pour application ungueale et peri-ungueale
CN101679063A (zh) 2007-05-24 2010-03-24 巴斯夫欧洲公司 疏水蛋白在固体结晶中作为添加剂的用途
JP2010539125A (ja) 2007-09-13 2010-12-16 ビーエーエスエフ ソシエタス・ヨーロピア 浸透増強剤としてのハイドロフォビンポリペプチドの使用
WO2010003811A1 (en) 2008-07-11 2010-01-14 Basf Se Amphiphilic proteins as morphology modifiers

Similar Documents

Publication Publication Date Title
JP2012518669A5 (https=)
JP2009268467A5 (https=)
JP2013515057A5 (https=)
HRP20140616T1 (hr) Peptidni analog oksintomodulina
RU2009128979A (ru) Hla*1101-ограниченный пептид wt1 и содержащая его фармацевтическая композиция
US10647742B2 (en) Method for synthesizing etelcalcetide
JP2018504419A5 (https=)
RU2016146198A (ru) Терапевтические dll4-связывающие белки
JP2011502964A5 (https=)
JP2013537400A5 (https=)
JP2013543497A5 (https=)
JP2005516072A5 (https=)
JP2021520818A5 (https=)
AR079114A1 (es) Proteinas de enlace de antigenos anti-orai1 y usos de las mismas
RU2017119773A (ru) Пептидные антагонисты пептидных гормонов из семейства кальцитонина (cgrp) и их применение
WO2005098435A3 (en) Peptides and peptidomimetics binding to cd23
CN106232616A (zh) 两亲性合成抗菌肽、其药物组合物及其用途
TW201629085A (zh) 芋螺毒素(conotoxin)肽之修飾及用途
JP2015504052A5 (https=)
JP2020513810A5 (https=)
WO2011038900A3 (en) Peptide analogues of glucagon for diabetes therapy
JP2012514466A5 (https=)
JP2008521795A5 (https=)
EA201100459A1 (ru) Композиции, включающие интерлейкин-1 и пептиды
KR20160091980A (ko) Psd-95의 이량체 억제제의 지방산 유도체